0001439222-24-000040.txt : 20240227 0001439222-24-000040.hdr.sgml : 20240227 20240227160446 ACCESSION NUMBER: 0001439222-24-000040 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240223 FILED AS OF DATE: 20240227 DATE AS OF CHANGE: 20240227 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schenkein David P CENTRAL INDEX KEY: 0001578200 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36014 FILM NUMBER: 24686443 MAIL ADDRESS: STREET 1: C/O BLUEBIRD BIO, INC. STREET 2: 840 MEMORIAL DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AGIOS PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001439222 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 88 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-649-8600 MAIL ADDRESS: STREET 1: 88 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: AGIOS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20080703 4 1 wk-form4_1709067874.xml FORM 4 X0508 4 2024-02-23 0 0001439222 AGIOS PHARMACEUTICALS, INC. AGIO 0001578200 Schenkein David P C/O AGIOS PHARMACEUTICALS, INC. 88 SIDNEY STREET CAMBRIDGE MA 02139 1 0 0 0 0 Common stock 2024-02-23 4 M 0 47731 31.64 A 170585 D Common stock 2024-02-23 4 S 0 47731 33.05 D 122854 D Common stock 2024-02-26 4 M 0 20411 31.64 A 143265 D Common stock 2024-02-26 4 S 0 20411 33.19 D 122854 D Common stock 270772 I See footnote Common stock 79082 I See footnote Stock option (right to buy) 31.64 2024-02-23 4 M 0 47731 0 D 2024-03-04 Common stock 47731 89740 D Stock option (right to buy) 31.64 2024-02-26 4 M 0 20411 0 D 2024-03-04 Common stock 20411 69329 D The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $33.00 to $33.27. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $33.00 to $33.59. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Shares held by David P. Schenkein 2004 Revocable Trust, of which the reporting person is trustee and beneficiary. Shares held by Amy P. Schenkein 2004 Revocable Trust, of which the reporting person's spouse is trustee and beneficiary. This option was originally granted on March 5, 2014 for the purchase of 148,770 shares of common stock. The shares underlying this option vested as to 25% of the underlying shares on March 5, 2015, with the remaining 75% vesting in 36 equal monthly installments thereafter. /s/ William Cook, as Attorney-in-fact for David Schenkein 2024-02-27